Ryuichi Ishida

1.4k total citations
76 papers, 1.1k citations indexed

About

Ryuichi Ishida is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Ryuichi Ishida has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 14 papers in Organic Chemistry. Recurrent topics in Ryuichi Ishida's work include Neuropeptides and Animal Physiology (9 papers), Pain Mechanisms and Treatments (8 papers) and Neuroscience and Neuropharmacology Research (8 papers). Ryuichi Ishida is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Pain Mechanisms and Treatments (8 papers) and Neuroscience and Neuropharmacology Research (8 papers). Ryuichi Ishida collaborates with scholars based in Japan, United States and Czechia. Ryuichi Ishida's co-authors include Takashi Ochiai, Michio Yamamura, Hiroyuki Nakagawa, Kiyoshi Kinoshita, Toyonari Oine, Ichizo Inoue, Yoshihisa Yamada, Hiroshi Sugano, Junichi Tani and Kazuo Matsumoto and has published in prestigious journals such as Nature Communications, Stroke and Brain Research.

In The Last Decade

Ryuichi Ishida

66 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuichi Ishida Japan 21 416 240 216 135 114 76 1.1k
Terence T. Yen United States 22 449 1.1× 125 0.5× 129 0.6× 70 0.5× 405 3.6× 48 1.4k
Naoyuki Yoshida Japan 23 405 1.0× 287 1.2× 181 0.8× 60 0.4× 225 2.0× 89 1.5k
J Krall United States 20 739 1.8× 51 0.2× 186 0.9× 354 2.6× 219 1.9× 62 1.5k
Jerome H. Fleisch United States 18 448 1.1× 89 0.4× 231 1.1× 164 1.2× 520 4.6× 51 1.2k
John P. Long United States 24 592 1.4× 374 1.6× 372 1.7× 54 0.4× 119 1.0× 115 1.7k
Hideaki Fukushima Japan 18 491 1.2× 247 1.0× 219 1.0× 81 0.6× 90 0.8× 65 1.3k
Gerhard Zbinden Switzerland 16 267 0.6× 81 0.3× 216 1.0× 173 1.3× 85 0.7× 46 1.1k
K. Steiner United States 17 288 0.7× 87 0.4× 102 0.5× 34 0.3× 260 2.3× 38 903
Takayuki Sukamoto United States 18 388 0.9× 94 0.4× 251 1.2× 37 0.3× 110 1.0× 66 1.1k
John Bondo Hansen Denmark 26 1.0k 2.5× 407 1.7× 333 1.5× 142 1.1× 129 1.1× 76 1.9k

Countries citing papers authored by Ryuichi Ishida

Since Specialization
Citations

This map shows the geographic impact of Ryuichi Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Ishida more than expected).

Fields of papers citing papers by Ryuichi Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Ishida. The network helps show where Ryuichi Ishida may publish in the future.

Co-authorship network of co-authors of Ryuichi Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Ishida. A scholar is included among the top collaborators of Ryuichi Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Ishida. Ryuichi Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kikuchi, Yasushi, Tomoki Tamakoshi, Ryuichi Ishida, et al.. (2023). Gene-Modified Blister Fluid–Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 143(12). 2447–2455.e8. 4 indexed citations
2.
Jin, Mingyue, Sakiko Matsumoto, Takashi Ayaki, et al.. (2022). DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers. Nature Communications. 13(1). 6880–6880. 19 indexed citations
3.
Iguchi, Tokuichi, et al.. (2017). Developmental downregulation of LIS1 expression limits axonal extension and allows axon pruning. Biology Open. 6(7). 1041–1055. 5 indexed citations
4.
Otaka, Michiro, Yuko Izumi, Naoto Sakamoto, et al.. (2010). Overexpression of a 60-kDa heat shock protein enhances cytoprotective function of small intestinal epithelial cells. Life Sciences. 86(13-14). 499–504. 35 indexed citations
5.
Sugawara, Taku, et al.. (2009). ANGIOTENSIN RECEPTOR BLOCKER CANDESARTAN BINDS TO AND UPREGULATES MOLECULAR CHAPERONE HSP90 IN THE HIPPOCAMPAL CA1 NEURONS ― A POSSIBLE MECHANISM OF NEUROPROTECTION BY ANGIOTENSIN RECEPTOR BLOCKER―. 36(1). 25–33. 1 indexed citations
6.
Sakai, Paulo, Rogério Kuga, Adriana Vaz Safatle‐Ribeiro, et al.. (2005). Is It Feasible to Reach the Bypassed Stomach after Roux-en-Y Gastric Bypass for Morbid Obesity? The Use of the Double-Balloon Enteroscope. Endoscopy. 37(6). 566–569. 81 indexed citations
7.
Ishida, Ryuichi, et al.. (1996). Induction of Cardiac Angiotensinogen mRNA and Angiotensin Converting Enzyme(ACE) Activity in Isoproterenol-Induced Heart Injury.. Hypertension Research. 19(3). 179–187. 12 indexed citations
9.
Yamamura, Michio, Kiyoshi Kinoshita, Hiroyuki Nakagawa, & Ryuichi Ishida. (1991). Pharmacological study of TA-0910, a new thyrotropin-releasing hormone(TRH) analog. (IV). Effects on experimental memory impairment in mice and rats.. The Japanese Journal of Pharmacology. 55(2). 241–253. 18 indexed citations
10.
Yamamura, Michio, Kiyoshi Kinoshita, Hiroyuki Nakagawa, & Ryuichi Ishida. (1991). Pharmacological study of TA-0910, a new thyrotropin-releasing hormone(TRH) analog(III): Inhibition of pentobarbital anesthesia.. The Japanese Journal of Pharmacology. 55(1). 69–80. 21 indexed citations
13.
Suzuki, Mamoru, Hiroshi Sugano, Kazuo Matsumoto, Michio Yamamura, & Ryuichi Ishida. (1990). Synthesis and central nervous system actions of thyrotropin-releasing hormone analog containing a dihydroorotic acid moiety. Journal of Medicinal Chemistry. 33(8). 2130–2137. 51 indexed citations
14.
Yamamura, Michio, Hiroyuki Nakagawa, Kiyoshi Kinoshita, Takashi Ochiai, & Ryuichi Ishida. (1988). A Behavioral Pharmacological Study of Mafoprazine, a New Phenylpiperazine Derivative. The Japanese Journal of Pharmacology. 48(2). 203–212.
15.
Yamamura, Michio, et al.. (1986). Behavioral pharmacological properties of nicergoline. Effects on gross-behavior in rats and monkeys and on DRL response, CER, and CAR in rats.. Folia Pharmacologica Japonica. 87(2). 209–221. 1 indexed citations
16.
Ochiai, Takashi, et al.. (1981). . Folia Pharmacologica Japonica. 78(4). 347–357. 3 indexed citations
17.
Kojima, Michio, Yukitsuka Kudo, & Ryuichi Ishida. (1981). Effects of afloqualone, a centrally acting muscle relaxant, on the sleep-wakefulness cycle in cats with chronically implanted electrodes. Folia Pharmacologica Japonica. 78(5-6). 471–482.
18.
Ishida, Ryuichi, et al.. (1976). Pharmacological studies of penfluridol. (I) The neuropharmacological properties. Folia Pharmacologica Japonica. 72(7). 795–813. 3 indexed citations
19.
Ochiai, Takashi, et al.. (1976). Pharmacological studies of penfluridol (II). The general pharmacological properties. Folia Pharmacologica Japonica. 72(5). 501–517. 2 indexed citations
20.
Ishida, Ryuichi, et al.. (1966). The effect of 2-Ethyl-3-methylvaleramide (V alnoctamide) on the central nervous system of the rabbit (Report 2). Folia Pharmacologica Japonica. 62(6). 414–426.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026